US Broker Ratings

Weave Communications, Inc. (WEAV) Stock Analysis: Navigating Healthcare Tech with a 15.5% Revenue Growth

Weave Communications, Inc. (NYSE: WEAV) is making waves in the healthcare technology sector with its innovative AI-driven solutions for patient communication and engagement. Headquartered in Lehi, Utah, Weave Communications is..

Vir Biotechnology, Inc. (VIR) Stock Analysis: Exploring the 90.27% Potential Upside

Vir Biotechnology, Inc. (NASDAQ: VIR), operating within the dynamic healthcare sector, is a clinical-stage biopharmaceutical company focused on developing innovative therapeutic products to combat serious infectious diseases. The company, founded..

Collegium Pharmaceutical, Inc. (COLL) Stock Analysis: A 118% Potential Upside Beckons Investors

Collegium Pharmaceutical, Inc. (NASDAQ: COLL), a prominent player in the healthcare sector, is garnering significant attention from investors, driven by its potential upside of 118.31%. With a market capitalization of..

Ardelyx, Inc. (ARDX) Stock Analysis: Unveiling a Potential 281% Upside in the Biotech Sector

Ardelyx, Inc. (NASDAQ: ARDX), a biotechnology firm based in Waltham, Massachusetts, is attracting significant attention from investors seeking opportunities in the healthcare sector. Specializing in the discovery and commercialization of..

Rocket Pharmaceuticals, Inc. (RCKT)

⚠️ No article content returned.

..

Claritev Corporation (CTEV) Stock Analysis: Unpacking a 44.45% Upside Potential in Healthcare Innovation

Claritev Corporation (CTEV), a notable player in the healthcare sector, is making waves with its comprehensive suite of data analytics and technology-enabled solutions. Headquartered in McLean, Virginia, Claritev specializes in..

Theravance Biopharma, Inc. (TBPH) Stock Analysis: Navigating the Biotech Seas with Strategic Collaborations

For investors eyeing the dynamic healthcare sector, Theravance Biopharma, Inc. (NASDAQ: TBPH) presents a fascinating proposition within the biotechnology industry. With a market capitalization of approximately $884.7 million, this South..

Arcus Biosciences (RCUS) Stock Analysis: Exploring a 51.72% Potential Upside in Biotechnology

Arcus Biosciences, Inc. (NASDAQ: RCUS) stands as a compelling player in the biotechnology sector, capturing investor interest with a notable potential upside of 51.72% according to analyst ratings. With a..

Castle Biosciences, Inc. (CSTL) Stock Analysis: A 19.63% Potential Upside in the Healthcare Sector

Castle Biosciences, Inc. (NASDAQ: CSTL) is capturing the attention of investors with its promising growth potential in the healthcare sector. Specializing in molecular diagnostics, the company offers innovative solutions for..

Cogent Biosciences, Inc. (COGT) Stock Analysis: Unveiling a Potential 68% Upside

Cogent Biosciences, Inc. (NASDAQ: COGT), a clinical-stage biotechnology firm, is becoming an intriguing prospect for investors seeking exposure in the healthcare sector, particularly within biotechnology. With a robust market capitalization..

Delcath Systems, Inc. (DCTH) Stock Analysis: A Potential 47.69% Upside in the Oncology Device Market

Delcath Systems, Inc. (DCTH), a healthcare player specializing in medical devices, has been gaining investor attention due to its innovative approach in the treatment of liver cancers. With a strategic..

Zenas BioPharma, Inc. (ZBIO): Analyst Ratings Suggest a 47% Upside in Biotech Investment

Zenas BioPharma, Inc. (NASDAQ: ZBIO), a clinical-stage biopharmaceutical company headquartered in Waltham, Massachusetts, is capturing investor attention with its promising pipeline of immunology-based therapies. With a market capitalization of $2.08..

LENZ Therapeutics, Inc. (LENZ): Analyzing the Potential 481% Upside for Investors

Investors with a keen eye on the biotechnology sector might find LENZ Therapeutics, Inc. (NASDAQ: LENZ) a compelling opportunity. With its current market cap of $129.77 million, the company is..

KalVista Pharmaceuticals, Inc. (KALV) Stock Analysis: Navigating Its Stable Price and Future Prospects

KalVista Pharmaceuticals, Inc. (KALV), listed on the U.S. market, stands as a notable entity in the biotechnology sector. With a market capitalization of $1.44 billion, the company specializes in developing..

Capricor Therapeutics (CAPR) Stock Analysis: Unpacking a 186.62% Potential Upside in Biotechnology

Capricor Therapeutics, Inc. (NASDAQ: CAPR), a clinical-stage biotechnology player, has captured the attention of investors with its promising pipeline and substantial potential upside. Operating in the healthcare sector and specializing..

CeriBell, Inc. (CBLL) Stock Analysis: Exploring the 12% Potential Upside in the Innovative Medical Device Sector

CeriBell, Inc. (CBLL), a key player in the healthcare sector, specifically within the medical devices industry, has captured the attention of investors with its innovative approach to acute care. The..

REGENXBIO Inc. (RGNX) Stock Analysis: Exploring a Potential 188.83% Upside in Biotech Innovation

For investors with an eye on biotech, REGENXBIO Inc. (NASDAQ: RGNX) offers a captivating opportunity driven by its innovative gene therapy solutions and significant potential upside. With a current stock..

Talkspace, Inc. (TALK) Stock Analysis: Exploring a 21.43% Potential Upside in the Digital Healthcare Sector

In an era where mental health awareness is gaining prominence, Talkspace, Inc. (NASDAQ: TALK) stands at the forefront of digital behavioral healthcare. With its innovative approach to connecting patients with..

Nutex Health Inc. (NUTX) Stock Analysis: Investor Optimism with a 32% Upside Potential

For investors in the healthcare sector, Nutex Health Inc. (NUTX) presents a compelling opportunity. This Houston-based company, with a market capitalization of $1.47 billion, is a key player in the..

Avanos Medical, Inc. (AVNS) Stock Analysis: Revenue Growth and Challenges in Focus for Healthcare Investors

For investors with an eye on the healthcare sector, Avanos Medical, Inc. (NYSE: AVNS) stands out as a significant player in the medical devices industry. With a market capitalization of..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds